Roche has been a leader in biomedical research since the
birth of the pharmaceutical industry. In 1896, Fritz Hoffmann, recently married to Adele La
Roche, established a small but successful pharmaceutical specialties company with a unique
objective: to develop and mass produce novel drugs of uniform strength and quality and then
market them internationally. One hundred years later, Fritz Hoffmann's single laboratory has
grown into Roche Holding Ltd., a world renowned, multinational health care organization
surpassing even its founder's expectations.
Today, Roche has one of the
strongest pipelines
in the pharmaceutical industry, the result of outstanding alliances with our partners and
complementing internal research. As of December 31, 2007, Roche has a total of 57 New Molecular
Entitles (NMEs) and 58 additional indications in its pipeline, including new products for
depression, diabetes, oncology and rheumatoid arthritis. Research is conducted in the
following Disease Biology Areas: central nervous system disorders;
inflammation, including respiratory and auto-immune diseases; metabolic diseases; oncology;
and virology, including HIV/AIDS and hepatitis C. For more information on innovative research
at Roche, click here.
Collaborations
Our goal is to bring our patients the best of modern medicine and we recognize that
breakthroughs are often found through collaborative efforts. One way Roche seeks innovation is
by partnering with dozens of companies in the industry.
Click here to learn
more.
Pipeline
Roche has a rich set of new and novel solutions in its product pipeline, clinically
differentiated compounds which build on our strengths in virology and oncology and extend
into our research new areas like inflammation.
Click here to
investigate Roche's entire pharmaceutical pipeline.
Clinical Trials
Our commitment to innovative medicine comes with an equally firm commitment to the
safety of our patients, which is why Roche is fully dedicated open and transparent clinical
trials. We register all of our studies with the federal
ClinicalTrials.gov database and we
also provide more detailed information at our own
Clinical Trials Registry and Results
Database.
Genetics, Genomics
More and more, modern medicine means personalized medicine. Genetics and genomics
research helps us understand predispositions to diseases and individual drug responses,
enabling us to contribute to personalized healthcare.
Click here to learn more.
Biotech
Roche has long been a leader in innovative medical research. Our cutting edge
biopharmaceuticals have lead to breakthroughs in the treatment of cancer and hepatitis C.
Click here to learn more.
|
